Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.
September 22, 2015
New Alzheimer trial to use epilepsy drug that calms brain activity
What could be one of the first treatments to delay or prevent Alzheimer’s disease received a big boost from the National Institute on Aging, which is putting up $7.5 million to help fund the next round of trials for the drug being developed by a Baltimore start-up and the Johns Hopkins University.
